Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Aikchol Hospital Public Company Limited operates a network of hospitals primarily in Thailand, focusing on providing high-quality healthcare services. The company differentiates itself through its advanced medical technology and specialized services, catering to both local and international patients, particularly in the areas of cardiology and orthopedics.
Aikchol generates revenue primarily through patient services, including inpatient and outpatient care, which are priced based on the complexity of treatments and procedures. The hospital's competitive advantage lies in its reputation for high-quality care, advanced medical technology, and a strong focus on patient satisfaction, allowing it to maintain pricing power in a competitive market.
Changes in healthcare regulations affecting reimbursement rates
Patient volume growth driven by marketing efforts and service expansion
Technological advancements in medical procedures enhancing service offerings
Economic conditions impacting consumer spending on healthcare services
Regulatory changes in healthcare policies that could impact reimbursement rates
Technological disruption from new healthcare delivery models or telemedicine
Increased competition from both local and international healthcare providers
Potential market entry of larger healthcare systems with more resources
Low liquidity risk due to a high current ratio of 6.54, but potential risks from unexpected capital expenditures for technology upgrades
Minimal financial risk related to debt obligations
moderate - healthcare spending is generally resilient, but economic downturns can lead to reduced elective procedures and outpatient visits.
Low - the company's minimal debt levels (Debt/Equity of 0.01) mean that rising interest rates have little impact on financing costs, but may affect consumer spending on healthcare services.
minimal - Aikchol's operations are not heavily reliant on credit markets, given its strong cash flow generation and low debt levels.
value - due to its low Price/Book ratio (0.9x) and stable cash flow generation, appealing to value-oriented investors.
low - historical volatility is moderate, reflecting the stability of healthcare demand.